Loading provider…
Loading provider…
Ophthalmology Physician in Las Vegas, NV
NPI: 1124041959Primary Practice Location
Green Valley Surgery Center
7365 S Pecos Rd, Las Vegas, NV
Primary Employer
Raymond Douglas, M.D., PHD a Professional Corporation
raymonddouglasmd.com
HQ Phone
Get MD, PHD Raymond's Phone Numberphone_androidMobile
Get MD, PHD Raymond's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
FL State Medical License
2023 - 2027
CA State Medical License
2002 - 2026
IL State Medical License
2023 - 2026
NV State Medical License
2023 - 2025
NY State Medical License
2014 - 2025
MI State Medical License
2008 - 2019
PA State Medical License
1999 - 2002

American Board of Ophthalmology
Ophthalmology
University of Pennsylvania Health System/Scheie Eye Institute
Residency • Ophthalmology
1999 - 2002
Perelman School of Medicine - Philadelphia
med.upenn.edu
Medical School
Until 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96413Infusion of chemotherapy into a vein up to 1 hour | 28 | 134 |
| 2 | J3241Injection, teprotumumab-trbw, 10 mg | 23 | 15,800 |
| 3 | J7050Infusion, normal saline solution , 250 cc | 22 | 74 |
| 4 | 92060Exam to measure eye deviation and range of motion | 21 | 99 |
| 5 | 92285Photography of content of eyes | 17 | 58 |
Teprotumumab for Active Thyroid Eye Disease. Reply.
Authors: Douglas, Raymond S, Kahaly, George J
Journal: N Engl J Med
Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy.
Authors: Hasan Syed
Journal: Am J Ophthalmol
Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.
Authors: Erin F. Gillespie, Nupur Raychaudhuri, Konstantinos I. Papageorgiou, Stephen J. Atkins, Ying Lu, Laya K. Charara, Tünde Mester, Terry J. Smith, Raymond S. Douglas
Publication Date: 2012-11
Lead Sponsor: Amgen
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: TEPEZZA
Lead Sponsor: Amgen
Intervention / Treatment: BIOLOGICAL: Teprotumumab
Lead Sponsor: Amgen
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Teprotumumab